Cancer Home > BCNU

Adults with certain types of cancer may receive chemotherapy treatment with a drug called BiCNU® (carmustine). This prescription medicine is specifically approved for use in adults and is licensed to treat the following cancers:
 
 
BiCNU belongs to a group of medicines known as alkylating agents. It contains the active drug carmustine, which is sometimes referred to as BCNU because its chemical name is bis-chloroethylnitrosourea.
 
This medicine works by interfering with the process needed for cells to grow and multiply. BiCNU is given as a slow injection into a vein (intravenous, or IV, infusion). Side effects may include nausea, vomiting, and low blood cell counts.
 
(To learn more about this chemotherapy drug, including more details on how it works, click BiCNU.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Advertisement
Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.